Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Jul. 31, 2020
Cash flows from operating activities
Net income	$ 24,464	$ 5,767
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	8,409	6,338
Amortization	8,918	6,029
Stock-based compensation expense	3,422	2,404
Deferred income taxes	441	1,454
Amortization of right-of-use assets	2,982	2,310
Non-cash interest expense	4,445	925
Inventory step-up amortization	0	4,772
Other non-cash items, net	8	(1,061)
Changes in assets and liabilities, net of effects of acquisitions/dispositions:
Accounts receivable	(10,302)	(348)
Inventories	4,214	(6,254)
Prepaid expenses and other assets	(1,206)	1,147
Accounts payable and other liabilities	10,221	(13,664)
Income taxes	9,284	1,450
Operating lease payments	(3,293)	(2,338)
Net cash provided by operating activities	62,007	8,931
Cash flows from investing activities
Capital expenditures	(5,495)	(10,390)
Proceeds from sale of businesses, net of cash retained	348	0
Acquisition of businesses, net of cash acquired	0	(658,932)
Net cash used in investing activities	(5,147)	(669,322)
Cash flows from financing activities
Proceeds from issuance of long term debt	0	400,000
Repayments of long-term debt	0	(2,375)
Borrowings under revolving credit facility	0	291,400
Repayments under revolving credit facility	(75,000)	(10,900)
Dividends paid	0	(9,234)
Contingent consideration payments	(103)	(127)
Purchases of treasury stock	(1,454)	(3,613)
Net cash (used in) provided by financing activities	(76,557)	665,151
Effect of exchange rate changes on cash and cash equivalents	(153)	(10)
(Decrease) increase in cash and cash equivalents	(19,850)	4,750
Cash and cash equivalents at beginning of period	277,871	44,535	$ 44,535
Cash and cash equivalents at end of period	$ 258,021	$ 49,285	$ 277,871